阿拉伯世界痴呆症的流行程度和经济负担
Tarik Qassem1, Lynn Itani2, Walid Nasr3
1Maudsley Health, Al-Amal Psychiatric Hospital, Dubai, UAE; Emirates Health Services, Al-Amal Psychiatric Hospital, Dubai, UAE; and Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE.
BJPsych open
|July 13, 2023
概括
痴呆症影响了阿拉伯世界超过130万人,每年花费超过100亿美元. 需要紧急投资于研究和为老年痴呆症患者提供服务.
科学领域:
- 公共卫生 公共卫生
- 老年学是一门学科.
- 卫生经济学 卫生经济学
背景情况:
- 痴呆症的患病率在全球范围内不断上升,在阿拉伯世界构成了重大挑战.
- 阿拉伯地区痴呆症的最新经济影响数据有限.
- 了解痴呆症的患病率和成本对于政策制定和支持系统至关重要.
研究的目的:
- 估计2021年阿拉伯国家的痴呆症患病率.
- 计算2021年阿拉伯地区痴呆症的经济成本.
主要方法:
- 利用联合国的人口数据和痴呆症患病率估计来确定总病例.
- 使用人均国内生产总值 (GDP) (PPP) 和收入分类计算直接痴呆成本.
- 估计的间接照顾者支持成本通过最佳情况和最坏情况的平均月薪.
主要成果:
- 黎巴嫩 (4.88%),突尼斯 (4.43%) 和阿尔及利亚 (4.19%) 在60岁以上的人群中患痴呆症的患病率最高.
- 对于50岁以上的人来说,总的直接痴呆成本超过了8180亿美元.
- 间接成本从2250亿美元到5670亿美元不等,平均为3980亿美元.
- 痴呆症护理总成本 (直接和间接) 平均为121.7亿美元,占该地区GDP的0.05%至0.44%.
结论:
- 痴呆症是阿拉伯世界日益严重的公共卫生问题,在2021年影响了1,329,729人.
- 痴呆症护理的总估计成本从10430亿美元到1390亿美元不等.
- 强调急需增加对痴呆症研究和老年人专业护理服务的投资.
相关概念视频
Dementia
141
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
141
Alzheimer's Disease: Overview
525
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
525
Prevalence and Incidence
634
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
634
Alzheimer's Disease: Treatment
219
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
219
Diagnostic and Statistical Manual of Mental Disorders (DSM)
97
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
97
Depressive Disorders: MDD and Dysthymia
176
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
176


